For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban ...
Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...
On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.
Oral: 30–45mL 3–4 times daily; may adjust dose every day or two to produce 2 ... Diabetes. Pregnancy (Cat.B). Nursing mothers.